Clinical trials
Recruiting Recurrence trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
186 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 2 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 5 |
| 2019 | 7 |
| 2020 | 4 |
| 2021 | 9 |
| 2022 | 18 |
| 2023 | 24 |
| 2024 | 29 |
| 2025 | 48 |
| 2026 | 28 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 186 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 13 |
| Regeneron Pharmaceuticals | 7 |
| UNC Lineberger Comprehensive Cancer Center | 6 |
| AstraZeneca | 5 |
| Yale University | 4 |
| ModernaTX, Inc. | 3 |
| Stanford University | 3 |
| University of Colorado, Denver | 3 |
| AbbVie | 2 |
| Baylor College of Medicine | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 186 |
| Neoplasms | 25 |
| Multiple Myeloma | 21 |
| Neoplasm Metastasis | 18 |
| Leukemia, Myeloid, Acute | 16 |
| Lymphoma, Non-Hodgkin | 16 |
| Lymphoma | 13 |
| Lymphoma, B-Cell | 10 |
| Lymphoma, Follicular | 10 |
| Hematologic Neoplasms | 9 |
Trials
Showing 1 to 25 of 186. Each trial links to its page on Pharma Observatory.
86 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.